Pfizer Korea to sell its consumer healthcare business to Johnson & Johnson Korea

Published: 2006-12-05 06:58:00

Updated: 2006-12-05 06:58:00

Pfizer Korea plans to sell its Consumer Healthcare (PCH) business to Johnson & Johnson Korea in the middle of this month following Pfizer Inc's decision to drive long-term growth in priority areas such as Alzheimer's disease, diabetes, obesity and infectious diseases.

Pfizer Consumer Healthcare had revenue of $3.9 billion in 2005. Its portfolio of well-known global brands includes Listerine,...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.